This review covers the role of eosinophils in asthma-associated tissue remodeling and angiogenesis focusing on angiogenesis which is a recently discovered feature of asthma. In addition, novel directions for eosinophil-targeted/angiogenesis-targeted pharmacological intervention are discussed as new approaches in the treatment of asthma.
Asai, K., Kanazawa, H., Kamoi, H., Shiraishi, S., Hirata, K. andYoshikawa, J. (2003) Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy33(5): 595-599.
2.
Asai, K., Kanazawa, H., Otani, K., Shiraishi, S., Hirata, K. andYoshikawa, J. (2002) Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J Allergy Clin Immunol110(4): 571-575.
3.
Asquith, K.L., Ramshaw, H.S., Hansbro, P.M., Beagley, K.W., Lopez, A.F. and Foster, P.S. (2008) The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation. J Immunol180(2): 1199-1206.
4.
Bandi, N. and Kompella, U.B. (2001) Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur J Pharmacol425(2): 109-116.
5.
Barnes, P.J. (1999) Effect of beta-agonists on inflammatory cells. J Allergy Clin Immunol104(2): S10-S17.
6.
Bochner, B.S. and Busse, W.W. (2005) Allergy and asthma. J Allergy Clin Immunol115(5): 953-959.
7.
Bussolino, F., Wang, M.J., Defilippi, P., Turrini, F., Sanavio, F., Edgell, C.J.S. et al. (1989) Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate . Nature337: 471-473.
8.
Bussolino, F., Ziche, M., Wang, J.M., Alessi, D., Morbidelli, L., Cremona, O. et al. (1991) In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest87(3): 986-995.
9.
Cantarella, G., Lampereur, L., Presta, M., Ribatti, D., Lombardo, G., Lazarovici, P. Et al. (2002) Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J16(10): 1307-1309.
10.
Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature438(7070): 932-936.
11.
Chetta, A., Zanini, A., Foresi, A., D'Ippolito, R., Tipa, A., Castagnaro, A. et al. (2005) Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy35(11): 1437-1442.
12.
Cho, J.Y., Miller, M., Baek, K.J., Han, J.W., Nayar, J., Lee, S.Y. et al. (2004) Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest113(4): 551-560.
13.
Cohn, L., Elias, J.A. and Chupp, G.L. (2004) Asthma: mechanisms of disease persistence and progression . Annu Rev Immunol22: 789-815.
14.
Coussens, L.M., Fingleton, B. and Matrisian, L.M. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science295(5564): 2387-2392.
15.
Cross, M.J. and Claesson-Welsh, L. (2001) FGF and VEGF function in angiogenesis: signaling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci22(4): 201-207.
16.
Doherty, T. and Broide, D. (2007) Cytokines and growth factors in airway remodeling in asthma. Curr Opin Immunol19(6): 676-680.
17.
Dunnill, M.S. (1960) The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol13: 27-33.
18.
Elovic, A., Wong, D., Weller, P., Matossian, K. and Galli, S. (1994) Expression of transforming growth factor-α and β messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol93(5): 864-869.
19.
Ferrara, N., Hillan, K.J. and Novotny, W. (2005) Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun333(2): 328-335.
20.
Flood-Page, P., Menzies-Gow, A., Phipps, S., Ying, S., Wangoo, A., Ludwig, M.S. et al. (2003) Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest112(7): 1029-1036.
21.
Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med1(1): 27-31.
22.
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M. et al. (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med8(2): 128-135.
23.
Hickey, M.M. and Simon, M.C. (2006) Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol76: 217-257.
24.
Holgate, S.T. (2004) Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease. Cytokine28(4-5): 152-157.
25.
Homer, R.J. and Elias, J.A. (2005) Airway remodeling in asthma: therapeutic implications of mechanisms. Physiology (Bethesda)20: 28-35.
26.
Horiuchi, T. and Weller, P.F. (1997) Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol17(1): 70-77.
27.
Hoshino, M., Takahashi, M. and Aoike, N. (2001) Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol107(2): 295-301.
28.
Humbles, A.A., Lloyd, C.M., McMillan, S.J., Friend, D.S., Xanthou, G., McKenna, E.E. et al. (2004) A critical role for eosinophils in allergic airways remodeling. Science305(5691): 1776-1779.
29.
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H. et al. (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature348(6301): 555-557.
30.
James, A. (2005) Airway remodeling in asthma. Curr Opin Pulm Med11(1): 1-6.
31.
Kariyawasam, H.H. and Robinson, D.S. (2007) The role of eosinophils in airway tissue remodelling in asthma. Curr Opin Immunol19(6): 681-686.
32.
Kelly, E.A. and Jarjour, N.N. (2003) Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med9(1): 28-33.
33.
Lee, C.G., Link, H., Baluk, P., Homer, R.J., Chapoval, S., Bhandari, V. et al. (2004) Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med10(10): 1095-1103.
34.
Lee, S.Y., Paik, S.Y. and Chung, S.M. (2005) Neovastat (AE-941) inhibits the airway inflammation and hyperresponsiveness in a murine model of asthma. J Microbiol43(1): 11-16.
35.
Lee,Y.C., Kwak,Y.G. and Song, C.H. (2002) Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol168(7): 3595-3600.
36.
Levi-Schaffer, F., Garbuzenko, E., Rubin, A., Reich, R., Pickholz, D., Gillery, P. et al. (1999) Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta). Proc Natl Acad Sci USA96(17): 9660-9665.
37.
Li, A., Dubey, S., Varney, M.L., Dave, B.J. and Singh, R.K. (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis . J Immunol170(6): 3369-3376.
38.
Li, X. and Wilson, J.W. (1997) Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med156(1): 229-233.
39.
Makinde, T., Murphy, R.F. and Agrawal, D.K. (2007) The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol85(5): 348-356.
40.
McDonald, D.M. (2001) Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med164(10 Pt 2): S39-S45.
41.
Menzies-Gow, A., Flood-Page, P., Sehmi, R., Burman, J., Hamid, Q., Robinson, D.S. et al. (2003) Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol111(4): 714-719.
42.
Munitz, A., Bachelet, I. and Levi-Schaffer, F. (2006) Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol118(5): 1082-1089.
43.
Nauck, M., Karakiulakis, G., Perruchoud, A.P., Papakonstantinou, E. and Roth, M. (1998) Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol341(2-3): 309-315.
44.
Nomura, S., Kanazawa, H., Hirata, K., Iwao, H. and Yoshikawa, J. (2005) Relationship between vascular endothelial growth factor and angiopoietin-2 in asthmatics before and after inhaled beclomethasone therapy. J Asthma42(2): 141-146.
45.
Okada, S., Kita, H., George, T.J., Gleich, G.J. and Leiferman, K.M. (1997) Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol17(4): 519-528.
46.
O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S. et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell88(2): 277-285.
47.
O'Reilly, M.S., Holmgren, L., Shing,Y., Chen, C., Rosenthal, R.A., Moses, M. et al. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell79(2): 315-328.
48.
Pégorier, S., Wagner, L.A., Gleich, G.J. and Pretolani, M. (2006) Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol177: 4861-4869.
49.
Phipps, S.,Ying, S., Wangoo, A., Ong,Y.E., Levi-Schaffer, F. and Kay, A.B. (2002) The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol169(8): 4604-4612.
50.
Piliponsky, A.M., Gleich, G.J., Bar, I. and Levi-Schaffer, F. (2002) Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. Mol Immunol38(16-18): 1369.
51.
Piliponsky, A.M., Gleich, G.J., Nagler, A., Bar, I. and Levi-Schaffer, F. (2003) Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor . Blood101(5): 1898-1904.
52.
Pugh, C.W. and Ratcliffe, P.J. (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med9(6): 677-684.
53.
Puxeddu, I., Berkman, N., Nissim Ben Efraim, A.H., Davies, D., Ribatti, D., Gleich, G.J. et al. (2008) The role of eosinophil major basic protein (MBP) in angiogenesis. Allergy (accepted).
54.
Puxeddu, I., Alian, A., Piliponsky, A.M., Ribatti, D., Panet, A. and Levi-Schaffer, F. (2005a) Human peripheral blood eosinophils induce angiogenesis. Int J Biochem Cell Biol37(3): 628-636.
55.
Puxeddu, I., Ribatti, D., Crivellato, E. and Levi-Schaffer, F. (2005b) Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol116(3): 531-536.
56.
Rochester, C.L., Ackerman, S.J., Zheng, T. and Elias, J.A. (1996) Eosinophil-fibroblast interaction. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol156(11): 4449-4456.
57.
Sabroe, I., Conroy, D.M., Gerard, N.P., Li, Y., Collins, P.D., Post, T.W. et al. (1998) Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo. J Immunol161(11): 6139-6147.
58.
Salcedo, R., Young, H.A., Ponce, M.L., Ward, J.M., Kleinman, H.K., Murphy, W.J. et al. (2002) Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol166(12): 7571-7578.
59.
Salvato, G. (2001) Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax56(12): 902-906.
60.
Schuler, W., Sedrani, R., Cottens, S., Haberlin, B., Schulz, M., Schuurman, H.J. et al. (1997) SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation64(1): 36-42.
61.
Schwingshackl, A., Duszyk, M., Brown, N. and Moqbel, R. (1999) Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol104(5): 983-989.
62.
Simcock, D.E., Kanabar, V., Clarke, G.W., O'Connor, B.J., Lee, T.H. and Hirst, S.J. (2007) Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. Am J Respir Crit Care Med176(2): 146-153.
63.
Solomon, A., Aloe, L., Pe'er, J.Frucht-Pery, J., Bonini, S., Bonini, S. et al. (1998) Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol102(3): 454-460.
64.
Temkin,V., Aingorn, H., Puxeddu, I., Goldshmidt, O., Zcharia, E., Gleich, G.J. et al. (2004) Eosinophil major basic protein: first identified natural heparanase-inhibiting protein. J Allergy Clin Immunol113(4): 703-709.
65.
Tomasek, J.J., Gabbiani, G., Hinz, B., Chaponnier, C. and Brown, R.A. (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol3(5): 349-363.
66.
Vignola, A.M. (2003) Effects of inhaled corticosteroids, leukotriene receptor antagonists, or both, plus long-acting beta2-agonists on asthma pathophysiology: a review of the evidence. Drugs63 (Suppl 2): 35-51.
67.
Vignola, A.M., Kips, J. and Bousquet, J. (2000) Tissue remodeling as a feature of persistent asthma . J Allergy Clin Immunol105(6 Pt 1): 1041-1053.
68.
Vignola, A.M., Mirabella, F., Costanzo, G., Di Giorgi, R., Gjomarkaj, M., Bellia, V. et al. (2003) Airway remodeling in asthma. Chest123(Suppl 3): 417S-422S.
69.
Ward, C. and Walters, H. (2005) Airway wall remodelling: the influence of corticosteroids . Curr Opin Allergy Clin Immunol5(1): 43-48.
70.
Wong, D.T., Elovic, A., Matossian, K., Nagura, N., McBride, J., Chou, M.Y. et al. (1991) Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood78(10): 2702-2707.
71.
Yousefi, S., Hemmann, S., Weber, M., Hölzer, C., Hartung, K., Blaser, K. et al. (1995) IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol154(10): 5481-5490.
72.
Zagai, U., Dadfar, E., Lundahl, J., Venge, P. and Skold, C.M. (2007) Eosinophil cationic protein stimulates TGF-beta1 release by human lung fibroblasts in vitro. Inflammation30(5): 153-160.
